The Risks or Lack Thereof of Migraine Treatments in Vascular Disease.

The Risks or Lack Thereof of Migraine Treatments in Vascular Disease. Headache. 2020 Jan 22;: Authors: Diener HC Abstract PREMISES: Patients with migraine have a co-morbidity with vascular diseases such as hypertension, coronary heart disease, and stroke. PROBLEM: This overview gives recommendations for the therapy of acute migraine attacks and for migraine  prevention in patients with vascular diseases. In particular, the use of triptans in patients with vascular diseases is discussed. POTENTIAL SOLUTIONS: Currently, there is a contraindication for the use of the triptans in patients with vascular disease, although there is no evidence that triptans increase the risk of heart attacks or stroke. PMID: 31967337 [PubMed - as supplied by publisher]
Source: Headache - Category: Neurology Authors: Tags: Headache Source Type: research